Share on StockTwits

Ekf Diagnostics Holding PLC (LON:EKF)‘s stock had its “buy” rating reiterated by investment analysts at FinnCap in a note issued to investors on Tuesday. They currently have a GBX 38 ($0.65) price objective on the stock. FinnCap’s target price indicates a potential upside of 43.40% from the company’s previous close.

Ekf Diagnostics Holding PLC (LON:EKF) traded down 0.93% during mid-day trading on Tuesday, hitting GBX 26.50. The stock had a trading volume of 227,505 shares. Ekf Diagnostics Holding PLC has a one year low of GBX 23.60 and a one year high of GBX 43.00. The stock has a 50-day moving average of GBX 25.82 and a 200-day moving average of GBX 32.53.

Other equities research analysts have also recently issued reports about the stock. Analysts at N+1 Singer reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note on Wednesday, June 18th. They now have a GBX 38 ($0.65) price target on the stock. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note on Monday, June 2nd. They now have a GBX 48 ($0.82) price target on the stock. Finally, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note on Tuesday, May 20th. They now have a GBX 48 ($0.82) price target on the stock. Five investment analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and a consensus price target of GBX 40.60 ($0.70).

EKF Diagnostics Holdings Plc designs, develops, manufactures and sells diagnostic instruments, reagents and certain ancillary products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.